Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 5:44 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 625–648 of 13,921 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Obesity
Interventions: TV modification, safety and injury prevention; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 2 Years to 5 Years
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Pain
Interventions: Conventional root canal treatment, Ultrasonic, Apical negative pressure, Combined Ultrasonic and negative pressure; Device
Lead sponsor: Cleveland Dental Institute; Other
Eligibility: 18 Years to 50 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Breast Cancer, Osteoporosis
Interventions: calcium carbonate, vitamin D, risedronate sodium, placebo; Dietary Supplement · Drug · Other
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older · Female only
Enrollment: 216 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 198
States / cities: Mobile, Alabama • Scottsdale, Arizona • Aurora, Colorado + 124 more

Conditions: Postoperative Abscess
Interventions: Oxygen Insufflation; Other
Lead sponsor: Chang, Steve S., M.D.; Individual
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Santa Barbara, California

Conditions: Bladder Cancer
Interventions: Educational Video Modules on Risk Prevention Before and After Cystectomy (Surgery), Geriatric Service/ Discharge Planning, Questionnaires; Other
Lead sponsor: University of Chicago; Other
Eligibility: 65 Years and older
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Head and Neck Squamous Cell Carcinoma
Interventions: afatinib, placebo; Drug · Other
Lead sponsor: ECOG-ACRIN Cancer Research Group; Network
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 272
States / cities: Anchorage, Alaska • Little Rock, Arkansas • Fort Collins, Colorado + 186 more

Conditions: Ischemic Stroke
Interventions: Low Dose Argatroban, High Dose Argatroban, rt-PA (alteplase); Drug
Lead sponsor: Andrew D. Barreto, MD; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Parkinson Disease, Dementia, Lewy Body, Delirium
Interventions: Music therapy intervention, Standard Care (in control arm); Behavioral · Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 60 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Obesity
Interventions: Group 1 (First trimester ultrasound), Group 2 (Second trimester anatomy ultrasound); Diagnostic Test
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 128 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Sarcoidosis Associated Pulmonary Hypertension
Interventions: Placebo, LAM-001; Drug
Lead sponsor: IRulya Therapeutics Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Emotions
Interventions: U-PEACE Intervention, SAU; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 13 Years to 18 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Coral Gables, Florida

Conditions: Discogenic Pain
Interventions: Bone Marrow Concentrate, Placebo; Other
Lead sponsor: APM Spine and Sports Physicians; Other
Eligibility: 18 Years to 55 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: Virginia Beach, Virginia

Conditions: Obesity (Body Mass Index &Amp;Amp;gt;30 kg/m2), Screening Colonoscopy
Interventions: Colonoscopy; Device
Lead sponsor: Cleveland Clinic Florida; Other
Eligibility: Not listed
Enrollment: 244 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Weston, Florida

Conditions: Stroke
Interventions: Hip Hop Stroke educational program, Nutrition Education program; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 7 Years and older
Enrollment: 4,614 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Cushing's Disease, Acromegaly
Interventions: Pasireotide s.c., Sitagliptin, Liraglutide, Insulin, Pasireotide LAR, Metformin; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 249 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 15
States / cities: Multiple Locations, California • Torrance, California • Ventura, California + 10 more

Conditions: Diabetes Mellitus, Type 1, Diabetic Ketoacidosis
Interventions: Glargine, IV insulin, Electrolyte Correction, Correction of Fluid Loss; Drug · Other
Lead sponsor: Chattanooga-Hamilton County Hospital Authority; Other
Eligibility: 1 Year to 21 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Chattanooga, Tennessee

Conditions: Influenza, Human
Interventions: NanoFlu, Fluzone Quadrivalent; Biological
Lead sponsor: Novavax; Industry
Eligibility: 65 Years and older
Enrollment: 2,654 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 19
States / cities: Hollywood, Florida • Savannah, Georgia • Stockbridge, Georgia + 16 more

Conditions: Abnormal Uterine Bleeding, Uterine Bleeding, Fibroid Uterus, Surgery
Interventions: Total Laparoscopic Hysterectomy; Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Staphylococcal Sepsis
Interventions: Placebo, Pagibaximab 50 mg/mL; Drug
Lead sponsor: Biosynexus Incorporated; Industry
Eligibility: Up to 48 Hours
Enrollment: 1,579 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Gaithersburg, Maryland

Conditions: Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer
Interventions: Ketorolac; Drug
Lead sponsor: New Mexico Cancer Research Alliance; Other
Eligibility: 18 Years and older · Female only
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Hip Pain
Interventions: Unrestrained Femoral Internal Rotation (UFIR) manipulation, Sham manipulation; Other
Lead sponsor: Andrews University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Columbia, Maryland

Conditions: Osteoarthritis, Knee
Interventions: PF-04191834, PF-04191834 placebo, Naproxen placebo, Naproxen; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 190 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 25
States / cities: Peoria, Arizona • Phoenix, Arizona • Anaheim, California + 20 more

Conditions: Childhood Cancer, Survivorship, Health Care Utilization, Health Knowledge, Attitudes, Practice, Adherence, Patient
Interventions: Multi-level Intervention of shared model of survivorship care, Comparison Group; Behavioral · Other
Lead sponsor: Georgetown University; Other
Eligibility: 2 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 4
States / cities: Long Beach, California • Denver, Colorado • Hackensack, New Jersey + 1 more

Conditions: Depression, Anxiety
Interventions: Emotionally Focused Therapy for Individuals, Self-Help CBT Training; Behavioral
Lead sponsor: Saint Paul University; Other
Eligibility: 18 Years and older
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Denver, Colorado

Search by objective public record fields.

Starting Healthy Staying Healthy Pilot Trial

Postoperative Pain After Activation of Irrigant

Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer

Oxygen Insufflation To Reduce Postoperative Abscess In Laparoscopic Appendectomy

Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy

Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence

Randomized Controlled Trial of Argatroban With Tissue Plasminogen Activator (tPA) for Acute Stroke

Music Therapy to Prevent Hospital-acquired Delirium in Parkinson's Disease and Dementia With Lewy Bodies

Early Anatomy Scan for Evaluation of Obese Pregnant Women (EASE-O)

LAM-001 for the Treatment of Sarcoidosis Associated Pulmonary Hypertension (SAPH)

Unified Protocol for Preventing Emotional and Academic Challenges in Education (U-PEACE)

Bone Marrow Concentrate Intradiscal Injection for Chronic Discogenic Low Back Pain

Randomized Controlled Trial Comparing Adult to Pediatric Colonoscope in Obese Patients.

Effect of Intervention to Improve Stroke Recognition

Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly

Early Administration of Long-acting Insulin Treatment of Diabetic Ketoacidosis in Pediatric Type 1 Diabetes

Phase 3 Pivotal Trial of NanoFlu™ in Older Adults

Outcomes on Abdominal Versus Vaginal Morcellation At Time of Hysterectomy

Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis

Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Hip Manipulation for Improved Strength in Patients With Hip Pain

A Study Of The Safety And Efficacy Of PF-04191834 In Patients With Osteoarthritis Of The Knee

A Multilevel Intervention to Improve Adherence to Childhood Cancer Survivorship

An Attachment Based Approach for Anxiety and Depression